Browsing Over 38 Presentations

Sort By
19:40 - 19:40 Satellite presentation MSD - Pembrolizumab: The new standard of care in advanced lung cancer Industry Satellite Symposium

Closing remarks (ID 47)

Presentation Topic
Satellite presentation
Lecture Time
19:40 - 19:40
Session Name
MSD - Pembrolizumab: The new standard of care in advanced lung cancer
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
19:10 - 19:25 Satellite presentation MSD - Pembrolizumab: The new standard of care in advanced lung cancer Industry Satellite Symposium

What’s next for Anti-PD-1 therapy in NSCLC (ID 21)

Presentation Topic
Satellite presentation
Lecture Time
19:10 - 19:25
Duration
15 Minutes
Session Name
MSD - Pembrolizumab: The new standard of care in advanced lung cancer
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
19:05 - 19:20 Satellite presentation Takeda Pharmaceuticals International AG - Let’s t-ALK+ NSCLC: Understanding the continuum of care Industry Satellite Symposium

How should we manage progression? Considerations for second-line therapy (ID 24)

Presentation Topic
Satellite presentation
Lecture Time
19:05 - 19:20
Duration
15 Minutes
Session Name
Takeda Pharmaceuticals International AG - Let’s t-ALK+ NSCLC: Understanding the continuum of care
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
19:20 - 19:30 Satellite presentation Takeda Pharmaceuticals International AG - Let’s t-ALK+ NSCLC: Understanding the continuum of care Industry Satellite Symposium

Are we running out of options? Third-line treatment and beyond (ID 25)

Presentation Topic
Satellite presentation
Lecture Time
19:20 - 19:30
Duration
10 Minutes
Session Name
Takeda Pharmaceuticals International AG - Let’s t-ALK+ NSCLC: Understanding the continuum of care
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
19:25 - 19:40 Satellite presentation MSD - Pembrolizumab: The new standard of care in advanced lung cancer Industry Satellite Symposium

Panel discussion (ID 44)

Presentation Topic
Satellite presentation
Lecture Time
19:25 - 19:40
Duration
15 Minutes
Session Name
MSD - Pembrolizumab: The new standard of care in advanced lung cancer
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
19:30 - 19:40 Satellite presentation Takeda Pharmaceuticals International AG - Let’s t-ALK+ NSCLC: Understanding the continuum of care Industry Satellite Symposium

Summary and close (ID 26)

Presentation Topic
Satellite presentation
Lecture Time
19:30 - 19:40
Duration
10 Minutes
Session Name
Takeda Pharmaceuticals International AG - Let’s t-ALK+ NSCLC: Understanding the continuum of care
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
18:40 - 18:55 Satellite presentation MSD - Pembrolizumab: The new standard of care in advanced lung cancer Industry Satellite Symposium

Anti-PD-1 monotherapy in metastatic NSCLC (ID 19)

Presentation Topic
Satellite presentation
Lecture Time
18:40 - 18:55
Duration
15 Minutes
Session Name
MSD - Pembrolizumab: The new standard of care in advanced lung cancer
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
12.04.2018, Thursday
Time
18:40 - 19:40
13:55 - 14:00 Satellite presentation Boehringer Ingelheim GmbH - Points of view: Opportunities and remaining hurdles in thoracic malignancies Industry Satellite Symposium

Meeting close (ID 57)

Presentation Topic
Satellite presentation
Lecture Time
13:55 - 14:00
Duration
5 Minutes
Session Name
Boehringer Ingelheim GmbH - Points of view: Opportunities and remaining hurdles in thoracic malignancies
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
13.04.2018, Friday
Time
13:00 - 14:00
13:45 - 13:50 Satellite presentation Pfizer Oncology - To sequence or not to sequence, that is the question: Maximising the outcomes of ALK inhibitors Industry Satellite Symposium

Panel discussion (ID 52)

Presentation Topic
Satellite presentation
Lecture Time
13:45 - 13:50
Duration
5 Minutes
Session Name
Pfizer Oncology - To sequence or not to sequence, that is the question: Maximising the outcomes of ALK inhibitors
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.04.2018, Friday
Time
13:00 - 14:00
13:00 - 13:05 Satellite presentation Boehringer Ingelheim GmbH - Points of view: Opportunities and remaining hurdles in thoracic malignancies Industry Satellite Symposium

Welcome and general introduction (ID 53)

Presentation Topic
Satellite presentation
Lecture Time
13:00 - 13:05
Duration
5 Minutes
Session Name
Boehringer Ingelheim GmbH - Points of view: Opportunities and remaining hurdles in thoracic malignancies
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
13.04.2018, Friday
Time
13:00 - 14:00
13:00 - 13:05 Satellite presentation Pfizer Oncology - To sequence or not to sequence, that is the question: Maximising the outcomes of ALK inhibitors Industry Satellite Symposium

Welcome and introduction (ID 48)

Presentation Topic
Satellite presentation
Lecture Time
13:00 - 13:05
Duration
5 Minutes
Session Name
Pfizer Oncology - To sequence or not to sequence, that is the question: Maximising the outcomes of ALK inhibitors
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.04.2018, Friday
Time
13:00 - 14:00
13:05 - 13:20 Satellite presentation Boehringer Ingelheim GmbH - Points of view: Opportunities and remaining hurdles in thoracic malignancies Industry Satellite Symposium

EGFR TKI sequencing: Does order matter? (ID 54)

Presentation Topic
Satellite presentation
Lecture Time
13:05 - 13:20
Duration
15 Minutes
Session Name
Boehringer Ingelheim GmbH - Points of view: Opportunities and remaining hurdles in thoracic malignancies
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
13.04.2018, Friday
Time
13:00 - 14:00